Now showing items 1-1 of 1

    • Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast Cancer. 

      Wei, X; Sun, L; Slade, E; Fierheller, CT; Oxley, S; Kalra, A; Sia, J; Sideris, M; McCluggage, WG; Bromham, N (2024-02-05)
      IMPORTANCE: Pathogenic variants (PVs) in BRCA1, BRCA2, PALB2, RAD51C, RAD51D, and BRIP1 cancer susceptibility genes (CSGs) confer an increased ovarian cancer (OC) risk, with BRCA1, BRCA2, PALB2, RAD51C, and RAD51D PVs also ...